Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Lakehouse leads pre-seed rounds for companies focused on urgent problems founded by focussed operators|Will Berkowitz,Partner,Lakehouse Ventures
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Will is a partner at Lakehouse Ventures.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Sanjay Purohit on Building Successful Teams and Cultivating a Vibrant Workplace at Sapphire Foods | Sanjay Purohit, CEO, Sapphire Foods India Ltd.
00:10:00
explain what makes their credit hedge fund|Mr. Jonathan Lewinsohn,Managing Partner,Diameter Capital Partners
00:10:00
As the president and CEO of AF Group, a national $3B+ specialty insurance organization, Lisa continues to strengthen the core principles driving the company's success.|Amund Tøftum is CEO in AF Gruppen
00:10:00
Navigating Utility Leadership and Customer Choice Amid Regulatory Changes and Environmental Challenges | Sean Trauschke, CEO, OGE Energy Corp.
00:10:00
6 Meridian Annual Investor Summit Highlights and Updates
00:10:00
Navigating Market Challenges: Insights from BTG Pactual | Roberto Sallouti, CEO , BTG Pactual Group.
00:10:00
Current Trends and Investment Themes in Battery Metals
00:10:00
Southern Silver Advancing Polymetallic Project in Durango's Fajada Plat
00:10:00
Francis MacDonald, CEO & Director of Li-FT Power, discussed innovations at VRIC 2024 on RCTV with host Mark Bunting.|Francis MacDonald, CEO & Director of Li-FT Power
00:00:00
Checkpoint Therapeutics aiming to be phase 3 ready - James F. Oliviero President & Chief Executive Officer, Checkpoint Therapeutics Inc
00:00:00
Alligator Bioscience - CEO Statement - Søren Bregenholt , CEO, Alligator Bioscience
00:10:00
Creating the Next Wave of Cancer Treatments for Patients | Athena Countouriotis, M.D. Chairperson, Avenzo Therapeutics